recombinant fhbp lipoprotein from neisseria meningitidis serogroup b rl2086 subfamily a

Spain

Drugs containing this active substance

  • TRUMENBA INJECTABLE SUSPENSION IN PRE-FILLED SYRINGE

    This vaccine is used to prevent invasive meningococcal disease caused by serogroup B meningococcus in individuals 10 years of age or older. This bacteria can cause serious infections such as meningitis or sepsis.

    Form: suspension for injection

    Active substance Dosage
    recombinant fhbp lipoprotein from neisseria meningitidis serogroup b rl2086 subfamily a 120 µg
    recombinant fhbp lipoprotein from neisseria meningitidis serogroup b rl2086 subfamily b 120 µg

    ATC: J07A J07AH J07AH09

    Manufacturer: Pfizer Europe Ma Eeig